Malaysia provides conditional okay to be used of Covid-19 therapy from Regeneron-Roche, SE Asia News & Top Stories


KUALA LUMPUR (REUTERS, THE STAR/ASIA NEWS NETWORK) – Malaysia’s well being ministry stated on Tuesday (Dec 14) it has given conditional approval for the usage of the single-dose antibody cocktail Ronapreve, developed by Regeneron and Roche, to deal with Covid-19.

It has additionally accredited a request from Merck & Co for a scientific trial import licence for its Covid-19 capsule Molnupiravir, for use as a part of research being performed in Malaysia, the ministry stated in a press release.

“Ronapreve is indicated for the treatment of Covid-19 in adults and adolescents aged 12 years and older and weighing at least 40kg who do not require supplemental oxygen for Covid-19 and who are at increased risk of progressing to severe Covid-19,” says Health director-general Dr Noor Hisham Abdullah within the assertion.

He stated the choice on utilizing the drug was made on the thirty seventh Drug Control Authority assembly on Monday.

Comments are closed.

buy levitra buy levitra online